COVID-19 and Acute Coronary Syndromes: Current Data and Future Implications
Matteo Cameli1, Maria Concetta Pastore1,2, Giulia Elena Mandoli1
1Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
Insights
The COVID-19 pandemic significantly impacted acute coronary syndromes (ACS) diagnosis and management, leading to fewer hospitalizations and potential future complications. Healthcare providers need to adapt strategies to mitigate these effects.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- The COVID-19 pandemic created a global healthcare crisis with significant mortality and morbidity.
- It raised clinical concerns regarding acute coronary syndromes (ACS) due to myocardial injury and management uncertainties.
Purpose of the Study:
- To review the impact of the COVID-19 pandemic on the diagnosis and management of ACS.
- To discuss potential future consequences and suggest adaptations in clinical and social approaches to ACS.
Main Methods:
- Literature review of available evidence on COVID-19 and ACS.
- Analysis of diagnostic and therapeutic challenges during the pandemic.
- Examination of hospitalization rates and patient care pathways.
Main Results:
- Reduced hospitalization rates for ACS were observed globally.
- Increased risk of short- and long-term complications from myocardial infarction is anticipated.
- Challenges in optimizing resources and protecting healthcare personnel were noted.
Conclusions:
- The pandemic necessitates a re-evaluation of ACS management strategies.
- Future approaches require enhanced healthcare provider efforts and adjusted patient engagement.
- Adapting diagnostic and therapeutic pathways is crucial for mitigating long-term impacts.
Abstract:
Coronavirus disease-2019 (COVID-19) pandemic is a global healthcare burden, characterized by high mortality and morbidity rates all over the world. During the outbreak period, the topic of acute coronary syndromes (ACS) has raised several clinical issues, due to the risks of COVID-19 induced myocardial injury and to the uncertainties about the management of these cardiologic emergency conditions, which should be organized optimizing the diagnostic and therapeutic resources and ensuring the maximum protection to healthcare personnel and hospital environment. COVID-19 status should be assessed as soon as possible. Moreover, considerably lower rates of hospitalization for ACS have been reported all over the world, due to patients' hesitations to refer to hospital and to missed diagnosis. As a result, short- and long-term complications of myocardial infarction are expected in the near future; therefore, great efforts of healthcare providers will be required to limit the effects of this issue. In the present review we discuss the impact of COVID-19 pandemic on ACS diagnosis and management, with possible incoming consequences, providing an overview of the available evidence and suggesting future changes in social and clinical approach to ACS.
More Related Videos
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:30Acute Coronary Syndrome I: Introduction
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Acute Coronary Syndrome V: Nursing Management
01:30Coronary Artery Disease III: Clinical Manifestations